BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
117 hedge funds and large institutions have $265M invested in BioSpecifics Technologies Corp. in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 43 reducing their positions, and 6 closing their positions.
167% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 6
9% more funds holding
Funds holding: 107 → 117 (+10)
1% more capital invested
Capital invested by funds: $263M → $265M (+$1.92M)
14% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 43
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$4.28M |
| 2 |
Renaissance Technologies
New York
|
+$4.25M |
| 3 |
MCM
Matarin Capital Management
New York
|
+$2.84M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.55M |
| 5 |
CCMG
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
+$2.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$13.2M |
| 2 |
BlackRock
New York
|
-$7.17M |
| 3 |
ECP
Elk Creek Partners
Denver,
Colorado
|
-$2.11M |
| 4 |
Goldman Sachs
New York
|
-$1.96M |
| 5 |
EP
Eversept Partners
New York
|
-$1.33M |
BSTC Hedge Fund Activity: Q1 2019 in Review
117 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2019, worth a combined $265M — up 0.73% from $263M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new BSTC positions and 6 closed out — a net gain of 10 holders — while 37 added to existing stakes and 43 trimmed.
The largest buyer was Rice Hall James & Associates, adding an estimated $4.28M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $13.2M sold.
- 117 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2019, up from 107 in Q4 2018.
- Funds reported $265M of BioSpecifics Technologies Corp. stock for Q1 2019, up 0.73% quarter-over-quarter.
- 16 funds opened new BioSpecifics Technologies Corp. positions in Q1 2019 and 6 closed out, a net change of +10 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q1 2019 was Rice Hall James & Associates, an estimated $4.28M added.
- The largest BioSpecifics Technologies Corp. seller in Q1 2019 was Stonepine Capital Management, an estimated $13.2M sold.
Based on aggregated 13F filings for Q1 2019.